News
DHR
--
0.00%
--
Peering Into Danaher's Recent Short Interest
Danaher's (NYSE:DHR) short percent of float has fallen 5.0% since its last report. The company recently reported that it has 4.92 million shares sold short, which is 0.76% of all regular shares that are available for trading.
Benzinga · 3d ago
Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?
Danaher Corporation ( NYSE:DHR ) saw significant share price movement during recent months on the NYSE, rising to highs...
Simply Wall St. · 4d ago
David Tepper's Appaloosa buys more Uber in Q1, exits Alliance Data
Billionaire hedge fund manager David Tepper's Appaloosa has increased its holdings in ride-hailing app Uber (NYSE:UBER) to 2.02M shares in the first quarter vs. 225K in Q4 2021, according to
Seekingalpha · 5d ago
BRIEF-Danaher Joins Bespoke Gene Therapy Consortium For Rare Diseases
reuters.com · 05/12 20:31
Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases
Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021, the BGTC will generate gene therapy resources that the research community can use to streamline gene therapy development for ...
PR Newswire · 05/12 20:30
Danaher declares $0.25 dividend
Danaher (NYSE:DHR) declares $0.25/share quarterly dividend, in line with previous. Forward yield 0.42% Payable July 29; for shareholders of record June 24; ex-div June 23. See DHR Dividend Scorecard, Yield
Seekingalpha · 05/10 20:23
The Zacks Analyst Blog Highlights Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing
Adobe, Danaher, Equinor, Advanced Micro Devices, and Automatic Data Processing are part of Zacks Top Analyst Blog.
Zacks · 05/10 11:43
Top Analyst Reports for Adobe, Danaher, Equinor & Others
Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Danaher Corporation (DHR), and Equinor ASA (EQNR).
Zacks · 05/09 19:01
RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics
FRAMINGHAM, Mass., May 09, 2022--At TIDES 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches the RNA 9000 Purity & Integrity kit, for the BioPhase 8800 system and PA 800 Plus syst...
Business Wire · 05/09 15:00
Danaher Unit Launches Equipment to Analyze mRNA Therapeutics, Vaccines
MT Newswires · 05/09 12:14
Danaher To Present At Bank Of America Securities Health Care Conference
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 11, 2022 at 10:00 a.m. PT. The audio w...
PR Newswire · 05/04 20:30
I Ran A Stock Scan For Earnings Growth And Danaher (NYSE:DHR) Passed With Ease
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Simply Wall St. · 05/02 19:25
Here's How Much $100 Invested In Danaher 10 Years Ago Would Be Worth Today
Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.71%. Currently, Danaher has a market capitalization of $180.36 billion.
Benzinga · 05/02 18:28
Analyzing Danaher's Short Interest
Danaher's (NYSE:DHR) short percent of float has risen 26.98% since its last report. The company recently reported that it has 5.19 million shares sold short, which is 0.8% of all regular shares that are available for trading.
Benzinga · 05/02 17:40
Insider Sell: Danaher
MT Newswires · 04/27 17:53
Analyst Ratings for Danaher
Danaher (NYSE:DHR) has observed the following analyst ratings within the last quarter:
Benzinga · 04/25 19:00
Top Analyst Reports for Alphabet, Amazon & Chevron
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Amazon.com, Inc. (AMZN), and Chevron Corporation (CVX).
Zacks · 04/25 18:15
Danaher downgraded as Wells Fargo shakes up life sciences coverage
Adjusting its ratings across the life sciences space on Monday, Well Fargo downgraded Danaher (NYSE:DHR) to Equal Weight from Overweight as the analyst Timothy Daley detailed risks to the key
Seekingalpha · 04/25 18:03
Thermo Fisher downgraded to underweight on valuation at Wells Fargo
Wells Fargo has downgraded life sciences company Thermo Fisher Scientific (NYSE:TMO) to underweight and lowered the price target from $605 to $525, citing an expensive valuation and "material headwinds for
Seekingalpha · 04/25 17:23
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
 
Benzinga · 04/25 14:07
Webull provides a variety of real-time DHR stock news. You can receive the latest news about Danaher Corporation through multiple platforms. This information may help you make smarter investment decisions.
About DHR
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.